Sintx Technologies, Inc. - SINT Company Value to Revenue Ratio

Public company logo of SINTX Technologies (SINT)

Sintx Technologies generates revenue from the supply of silicon nitride ceramics for aviation and spinal surgery, adhering to environmental standards through lean manufacturing. The enterprise value-to-revenue multiple demonstrates the company's stabilization in its maturity phase, and this metric has reached the level of 2996.98. The resilience of refractory material supply chains supports high margins and protects assembly lines from shortages.

SINT Sintx Technologies, Inc.: EV/Sales Multiple in the range 11/23/2025 - 11/20/2026

SINT (sintx.com): analytical breakdowns and indicator data

- price and consensus price forecast:
Fundamental valuation:Sintx Technologies Inc SINT
Mass-produced product of Sintx Technologies

Sintx Technologies diversification into aerospace and medical ceramics stabilizes cash flows, allowing this indicator to assess the business's resilience to industry shocks. By analyzing the enterprise value to annual revenue ratio, an investor sees the market value of assets net of debt, where the chart's break from a sideways trend indicates a shift in the company's fundamental attractiveness.

Competitor analysis for Sintx Technologies

BSX (Boston Scientific) - Company Value to Revenue Ratio|EW: EV/Sales Multiple|RMD - Total Company Value-to-Revenue Ratio|PODD (Insulet Inc.) - EV/Sales Multiple|Company Value to Revenue Zimmer Biomet Corp (ZBH)|EV/Sales Multiple COO|Company Value to Revenue Align Technology, Inc. ALGN|EV/Sales Multiple GMED (globusmedical.com)|EV/Sales Multiple TransMedics Group, Inc. TMDX|ATEC - Enterprise Value-to-Revenue Ratio|AORT: Enterprise Value-to-Revenue Ratio|ENOV (Enovis Corporation) - Company Value to Revenue|Integra LifeSciences - Business Value to Revenue|ESTA (Establishment Labs Inc) - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple Beta Bionics, Inc. BBNX|Enterprise Value-to-Revenue Ratio IRADIMED Corp (IRMD)|Embecta Corp. (EMBC) - Enterprise Value-to-Sales Ratio|Tandem Corp - Company Value to Revenue|EV/Sales Multiple AxoGen, Inc. AXGN|SI-BONE Inc - EV/Sales Multiple|Total Company Value-to-Revenue Ratio Orthofix Medical OFIX|Bioventus Global (BVS) - Enterprise Value-to-Revenue Ratio|Enterprise Value to Sales Volume KIDS (OrthoPediatrics Inc.)|Enterprise Value-to-Revenue Ratio treace.com|Company Value to Revenue Strata Critical Medical Inc (SRTA)|EV/Sales Multiple CARL|RXST - Enterprise Value-to-Revenue Multiple|Enterprise Value-to-Revenue Ratio clearpointneuro.com CLPT|STXS: Company Value to Revenue Ratio|STIM: Company Value to Revenue|sightsciences.com - Enterprise Value-to-Revenue Coefficient|Orchestra BioMed Inc. (OBIO) - Enterprise Value-to-Revenue Ratio|Anika (ANIK) - EV/Sales Multiple|Enterprise Value-to-Revenue Ratio InspireMD, Inc.|zhjmedical.com (ZJYL) - Total Company Value-to-Revenue Ratio|Company Value to Revenue VANI (Vivani Medical)|EV/Sales Multiple Xtant Medical Holdings, Inc. (XTNT)|Enterprise Value-to-Revenue Ratio NeuroOne Medical Technologies Corporation NMTC|EV/Sales Multiple Modular Medical MODD|MYO: Company Value to Revenue|Enterprise Value-to-Revenue Multiple Envoy Medical, Inc.|VVOS (Vivos Therapeutics) - Company Value to Revenue|Company Value to Revenue Ratio NVNO|Enterprise Value-to-Revenue Ratio Tenon Medical Inc.|LFWD: Business Value to Revenue|EV/Sales Multiple AMIX|Enterprise Value-to-Revenue Coefficient IVF|Enterprise Value-to-Revenue Ratio Bone Biologics BBLG|Total Company Value-to-Revenue Ratio axonics.com (AXNX)|BIOL - Enterprise Value-to-Revenue Ratio|Dynatronics (DYNT) - Company Value to Revenue|Paragon 28, Inc. (FNA) - Enterprise Value-to-Revenue Ratio|INVO - Total Company Value-to-Revenue Ratio